Lido King Lidocaine 4% Pain Relieving Gel-Patch

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Lido King Lidocaine 4% Pain Relieving Gel-Patch
Generic name
LIDOCAINE
Manufacturer
Galaxy Bio, Inc.
Product type
HUMAN OTC DRUG
SPL set ID
2243734a-4ea2-a5e5-e063-6294a90aba15
SPL ID
236362ce-50c3-7aee-e063-6394a90a580f
Version
2
Effective date
2024-10-01
Source export date
2026-10-27
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-27/2eee27992d1f29d82f827fd5be42f1314ed39ce4c497af5d81435ac6656a0957/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run
20261027T193451Z
Imported at
2026-10-27 20:27:03
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use if you are allergic to any ingredients of this product more than one patch at a time on wounds or damaged skin with a heating pad if pouch is damaged or opened When using this product avoid contact with the eyes, mucous membranes or rashes use only as directed do not bandage tightly do not reuse patch Stop use and ask a doctor if localized skin reactions occur, such as rash, itching, redness, irritation, pain, swelling and blistering symptoms clear up and occur again within a few days symptoms persist for more than 7 days conditions worsen If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.